Drug Target Review: Pinpointing function in cancer T cells could be new immunotherapy
UC research has found that increasing a certain function in cancer T cells could mean a new therapy
A previously unknown T cell mechanism that could explain the reason behind decreased immune function in cancer patients has been discovered. According to University of Cincinnati researchers, their finding may present a new immunotherapeutic target for patients with head and neck cancers.
The study, led by Laura Conforti and Ameet Chimote, in the Division of Nephrology and Hypertension, UC Department of Internal Medicine, revealed that a reduced interaction between a molecule called calmodulin and the ion channel KCa3.1 in the immune cells of cancer patients plays an important role in the limited function of these cells. The team performed experiments on cytotoxic T cells taken from the blood of patients with head and neck cancer.
Featured photo courtesy of Laura Conforti and Ameet Chimote.
Related Stories
UC student leaders prioritize well-being, collaboration and spirit
April 28, 2026
Wilaini Alicea and Zohair Siddiqui were elected UC student body president and student body vice president in March. The two student leaders discuss their priorities for student government.
Emeriti professors make $1 million gift to UC’s College of Medicine
April 28, 2026
Henry A. Nasrallah’s life’s work has been focused on helping others. His vocation as a psychiatrist, researcher and educator is closely intertwined with his personal commitment to philanthropy, reflecting a deep dedication to improving psychiatric care, particularly by advancing research in neurobiology and treatments for schizophrenia and related disorders.
Hoxworth, FC Cincinnati celebrate life-saving donors with exclusive May giveaway
April 27, 2026
Hoxworth Blood Center, University of Cincinnati, is asking donors to score big for their community this May with an exclusive 40 oz. FC Cincinnati–themed tumbler available to donors at the seven neighborhood donor centers and select mobile drives while supplies last.